Covaxin

Bhubaneswar: Odisha will receive another consignment of COVID-19 vaccine ‘Covaxin’ within a week which will be used in Bhubaneswar only. This was informed by the State Vaccine In-charge and Health and Family Welfare Director Bijay…

Bhubaneswar: As apart of World’s Largest Vaccination Campaign launched by Prime Minister Narendra Modi, to bring the COVID-19 pandemic under control, all the Railway Health Workers including Doctors, Paramedical Staff and other Medical…

New Delhi: The Union Minister of Health & Family Welfare, Dr. Harsh Vardhan, today reviewed preparations for the launch of the nationwide COVID-19 vaccination drive scheduled to begin tomorrow. The Union Minister visited the Dedicated…

New Delhi: The Centre has disapproved the authorisation of Bharat Biotech's Covid vaccine to people below 18 years of age whereas earlier, it was approved for children above the age of 12 years by the Drugs Controller General of India…

New Delhi: Prime Minister Narendra Modi will launch the pan India rollout of COVID-19 vaccination drive on 16th January, 2021 at 10:30 AM via video conferencing.  This will be the world’s largest vaccination program covering the entire…

Bhubaneswar: Bharat Biotech's Covaxin, which reached Odisha today, will be administered to people residing in the State capital Bhubaneswar, informed Odisha Health Director and Vaccine In-charge Dr Bijay Panigrahi today. While Covaxin…

Bhubaneswar: A day after receiving COVID-19 vaccine Covishield from Serum Institute of India, Odisha on Wednesday received its first consignment of 'Covaxin' from Bharat Biotech. As many as 20,000 doses of vaccines landed at Biju Patnaik…

Bhubaneswar: Odisha Chief Minister Naveen Patnaik has called the DCGI approval of Serum Institute of India and Bharat Biotech COVID-19 vaccines, a matter of great pride. The Drugs Controller General of India today approved two "Made in…

New Delhi: In a major development, the Drug Controller General of India (DCGI) has approved the two vaccines, Oxford-AstraZeneca Covishield and Bharat Biotech's Covaxin, for restricted use in India. The DCGI addressed a press conference…

New Delhi: The Subject Expert Committee of Central Drug Standard Control Organisation has approved emergency use of Oxford-AstraZeneca’s ‘Covishield’ vaccine. The final approval, however, rests with the Drugs Controller General of India…